These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23789)

  • 21. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of a beta blockader (SD/1601) associated with a tranquilizing agent (Camazepam) on systemic and coronary hemodynamic modifications due to induced emotional stress in the conscious dog].
    Brusoni B; Merlo L; Marchetti G
    Boll Soc Ital Biol Sper; 1977 Mar; 53(6):445-9. PubMed ID: 20907
    [No Abstract]   [Full Text] [Related]  

  • 23. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
    Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
    Karppanen H; Lahovaara S; Mattila MJ
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
    Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
    Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics.
    Inoue M; Hori M; Nakajima S; Kitakaze M; Fukunami M; Ishida Y; Abe H
    Arzneimittelforschung; 1984; 34(3A):355-9. PubMed ID: 6540088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative studies of antihypertensive effects of several beta-blocking agents in conscious rats (author's transl)].
    Ozawa H; Watanabe H; Chen CS
    Nihon Yakurigaku Zasshi; 1978 Jan; 74(1):139-44. PubMed ID: 25230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Independent measurements of the distribution of blood flow from the left circumflex coronary artery and the other coronary arteries (author's transl)].
    Nose Y
    Fukuoka Igaku Zasshi; 1978 Jun; 69(6):268-87. PubMed ID: 29001
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the duration of the effect of a single dose of nadolol on the product frequency x tension during exercise (author's transl)].
    Donzeau JP; Birmacker A; Bernadet P; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1978 Oct; 27(5):407-9. PubMed ID: 32825
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of a new adrenergic beta-blocking agent, Kö 1400 on the canine heart-lung preparation supported by a donor dog and the perfused hindlimb preparation of the dog (author's transl)].
    Nakagawa Y; Takeda K; Katano Y; Tsukada T; Matsubara I
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):411-21. PubMed ID: 20393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
    Hayase N; Chiba K; Ichihara K; Inagaki S; Abiko Y
    J Pharm Pharmacol; 1990 Jun; 42(6):419-22. PubMed ID: 1979622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intracisternal butoxamine, a beta-2 adrenoceptor blocking agent, on blood pressure and heart rate in the dog.
    Montastruc JL; Montastruc P
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):132-8. PubMed ID: 7387255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of nitroglycerin and of the combination of nitroglycerin and beta inhibitors on systemic and coronary hemodynamics and on cardiac metabolism].
    Marchetti GV; Merlo L; Brusoni B
    Boll Soc Ital Cardiol; 1975; 20(10):1197-205. PubMed ID: 10931
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasodilating beta-adrenoceptor blocking drugs do not redistribute myocardial flow during acute coronary ligation in dogs.
    Berdeaux A; Bonhenry C; Giudicelli JF
    Eur J Pharmacol; 1985 Jun; 112(3):379-85. PubMed ID: 2862054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of beta-adrenergic receptor blockade on the physiologic response to dobutamine stress echocardiography.
    Weissman NJ; Levangie MW; Newell JB; Guerrero JL; Weyman AE; Picard MH
    Am Heart J; 1995 Aug; 130(2):248-53. PubMed ID: 7631603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a coronary vasodilating substance, carbocromen, on the coronary blood flow under hypoxia and administration of adrenergic blocking agents.
    Koyama T; Nakagawa K; Marutani Y
    Arzneimittelforschung; 1972 Mar; 22(3):502-7. PubMed ID: 4402602
    [No Abstract]   [Full Text] [Related]  

  • 39. Regional myocardial tissue blood flow during sequential beta 1- and beta 2-adrenergic blockade in cat hearts with acute ischaemia.
    Grong K; Stangeland L; Lekven J
    Scand J Clin Lab Invest; 1983 Dec; 43(8):647-55. PubMed ID: 6141636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms (author's transl)].
    Rostan A
    Schweiz Rundsch Med Prax; 1978 Jan; 67(1):27-35. PubMed ID: 23523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.